Prognostic value of the 6-min walk test derived attributes in patients with idiopathic pulmonary fibrosis

被引:2
|
作者
Bloem, Ada E. M. [1 ,2 ,3 ]
Dolk, Hanneke M. [2 ,3 ]
Wind, Anne E. [2 ,3 ]
van der Vis, Joanne J. [2 ,3 ,4 ]
Kampen, Maarten J. [2 ,3 ]
Custers, Jan W. H. [1 ]
Spruit, Martijn A. [5 ,6 ,7 ]
Veltkamp, Marcel [2 ,3 ,8 ]
机构
[1] Univ Appl Sci Utrecht, Inst Movement Studies, Fac Hlth Care, Utrecht, Netherlands
[2] St Antonius Hosp, Interstitial Lung Dis Ctr Excellence, Dept Pulmonol, Nieuwegein, Netherlands
[3] European Reference Network Lung, Nieuwegein, Netherlands
[4] St Antonius Hosp, Dept Clin Chem, Nieuwegein, Netherlands
[5] CIRO, Dept Res & Dev, Horn, Netherlands
[6] Maastricht Univ Med Ctr MUMC, Dept Resp Med, Maastricht, Netherlands
[7] Fac Hlth Med & Life Sci, NUTRIM, Inst Nutr & Translat Res Metab, Maastricht, Netherlands
[8] Univ Med Ctr Utrecht, Div Heart & Lungs, Utrecht, Netherlands
关键词
Idiopathic pulmonary fibrosis (IPF); 6-min walk test (6MWT); Functional exercise capacity; Prognostic; Physiotherapy; GAP (Gender-Age-Physiology) model; CLINICAL-PRACTICE; DISTANCE; SURVIVAL; STANDARDIZATION; PIRFENIDONE; MORTALITY; SOCIETY; UPDATE;
D O I
10.1016/j.rmed.2024.107862
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Idiopathic pulmonary fibrosis (IPF) is a fatal progressive fibrosing lung disease. A decreased 6-min walk distance (6MWD) and exercise-induced oxygen desaturation measured during the 6-min walk test (6MWT), are known predictors of mortality in patients with IPF. However, the use of antifibrotic drugs showed a survival benefit in IPF. Therefore, this study aimed to evaluate to what extend 6MWT-derived attributes are associated with two-year survival when antifibrotic drugs were introduced as part of standard IPF-care. Methods: This real-world data-study included patients with IPF with a 6MWT between 2015 and 2020, and used composite outcome: mortality or lung transplantation within 2 years of follow-up. Data were collected systematically, including demographics, pulmonary function tests, comorbidities, medications and 6MWT-derived attributes. The prediction attributes of 6MWT were studied with a Cox Proportional-Hazards model and Kaplan-Meier survival curves. The best discriminating attribute to predict mortality was added to the prediction model Gender-Age-Physiology (GAP). Results: In 216 patients, 2-year transplant-free survival cut-off points were identified for the 6MWD (>= 413 m), 6MWD %predicted (>= 83 %), SpO2-nadir (>= 86 %) and distance-saturation-product (>= 374 m%), with the best discriminative value for SpO2-nadir (area under the curve: 0.761). 2-Year survival percentage of patients with SpO2-nadir below or above threshold (86 %) was 37.1 % and 80.0 %, respectively. Exercise-induced oxygen desaturation added to the GAP model showed an improvement in its predictive power. Conclusion: Patients with IPF who have an exercise-induced oxygen desaturation have worse prognosis. Addition of SpO2-nadir to the GAP model seems promising for use in clinical care of IPF patients.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] The correlation between 6-min walk test and respiratory parameters in children with cystic fibrosis
    Zahra Roshanzamir
    Rohola Shirzadi
    Mohammadreza Modaresi
    Irish Journal of Medical Science (1971 -), 2022, 191 : 289 - 294
  • [32] The correlation between 6-min walk test and respiratory parameters in children with cystic fibrosis
    Roshanzamir, Zahra
    Shirzadi, Rohola
    Modaresi, Mohammadreza
    IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 (01) : 289 - 294
  • [33] Prognostic importance of changes in 6-min walk test during titration of pharmacotherapy in HFrEF
    Myhre, P. Peder Langeland
    Kleiven, O.
    Gullestad, L.
    Grundtvig, M.
    Orn, S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 69 - 69
  • [34] Heart rate recovery after the 6-min walk test is related to 6-min walk distance and percutaneous oxygen saturation recovery in patients with COPD
    Shiroishi, Ryota
    Kitagawa, Chika
    Miyamoto, Naomi
    Kakuno, Nao
    Koyanagi, Harumi
    Rikitomi, Naoto
    Senjyu, Hideaki
    RESPIROLOGY, 2015, 20 (04) : 671 - 673
  • [35] Effect of 6-min Walk Test on pro-BNP Levels in Patients with Pulmonary Arterial Hypertension
    Pathak, Vikas
    Aris, Robert
    Jensen, Brian C.
    Huang, Wei
    Ford, Hubert James
    LUNG, 2018, 196 (03) : 315 - 319
  • [36] Effect of 6-min Walk Test on pro-BNP Levels in Patients with Pulmonary Arterial Hypertension
    Vikas Pathak
    Robert Aris
    Brian C. Jensen
    Wei Huang
    Hubert James Ford
    Lung, 2018, 196 : 315 - 319
  • [37] Validity of 6-min Walk Test in Assessment of Severity among Patients with Chronic Obstructive Pulmonary Disease
    Dave, Lokendra
    Rajoriya, Vivek
    Dube, T. N.
    Yadav, B. S.
    Shrivastava, Nishant
    Sharma, V. K.
    INTERNATIONAL JOURNAL OF SCIENTIFIC STUDY, 2016, 3 (10) : 67 - 71
  • [38] Prognostic Value of 6-Min Walk Test to Predict Postoperative Cardiopulmonary Complications in Patients With Non-small Cell Lung Cancer
    Lee, Hyun
    Kim, Hong Kwan
    Kang, Danbee
    Kong, Sunga
    Lee, Jae Kyung
    Lee, Genehee
    Shin, Sumin
    Cho, Juhee
    Zo, Jae Ill
    Shim, Young Mog
    Park, Hye Yun
    CHEST, 2020, 157 (06) : 1665 - 1673
  • [39] Test-retest reliability of the 6-min walk test in patients with postpolio syndrome
    Skough, Katarina
    Broman, Lisbet
    Borg, Kristian
    INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH, 2013, 36 (02) : 140 - 145
  • [40] The 6-min walk test:: a useful test in elderly patients with heart failure? -: Response
    Maldonado-Martin, Sara
    Brubaker, Peter H.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2007, 39 (02): : 392 - 392